Literature DB >> 18004146

Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.

Karen A Mathewson, J-P Lindenmayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18004146     DOI： 10.1097/JCP.0b013e31815a583b

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

2.  Successful rechallenge with clozapine following 'red alert'.

Authors:  Thelma K Toni-Uebari; John Rees
Journal:  BMJ Case Rep       Date:  2013-01-22

3.  Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia.

Authors:  Al Aditya Khan; Jake Harvey; Samrat Sengupta
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

4.  Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion.

Authors:  Allison Karst; Jonathan Lister
Journal:  Ment Health Clin       Date:  2018-08-30

5.  Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.

Authors:  Laurent Béchard; Olivier Corbeil; Maude Plante; Marc-André Thivierge; Charles-Émile Lafrenière; Marc-André Roy; Marie-France Demers
Journal:  J Psychopharmacol       Date:  2021-07-06       Impact factor: 4.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.